← Open Payments lookup

JACQUELYN DANESHFOROUZ: Open Payments

NPI 1649728775 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,808 in 93 payments from 14 companies in 2025. Trend: 2023 $2,616 · 2024 $2,825 · 2025 $4,808

Food & beverage: $3,008Consulting: $1,800
CompanyPaymentsAmount
PFIZER INC.10$2,160
Janssen Biotech, Inc.33$1,031
Madrigal Pharmaceuticals17$781
Takeda Pharmaceuticals U.S.A., Inc.13$174
Ardelyx, Inc.5$153
Boston Scientific Corporation1$144
Celltrion USA Inc.4$100
GlaxoSmithKline, LLC.1$60
Aimmune Therapeutics, Inc.2$55
ABBVIE INC.2$45

Products named: VELSIPITY, TREMFYA, REZDIFFRA, IBSRELA, General - Biliary Devices, ENTYVIO, VEGZELMA, XELJANZ.

Industry payments across NV — which companies pay providers there.